Tag Archives: Dr. Elias Zerhouni

Sanofi and MyoKardia, Inc. join forces to discover and develop first-of-its-kind targeted therapeutics for heritable heart diseases known as cardiomyopathies

Up to $200 Million Collaboration to Support Pioneering Science and New Treatments Paris and South San Francisco, CA, 18-9-2014 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) and MyoKardia, Inc., a privately-held company leading the development of precision therapies for genetic … Read the full press release